Exelon en es it fr

Exelon Brand names, Exelon Analogs

Exelon Brand Names Mixture

  • No information avaliable

Exelon Chemical_Formula

C14H22N2O2

Exelon RX_link

http://www.rxlist.com/cgi/generic2/rivastig.htm

Exelon fda sheet

Exelon FDA

Exelon msds (material safety sheet)

Exelon Synthesis Reference

No information avaliable

Exelon Molecular Weight

250.337 g/mol

Exelon Melting Point

No information avaliable

Exelon H2O Solubility

No information avaliable

Exelon State

Solid

Exelon LogP

2.611

Exelon Dosage Forms

Capsule; Solution

Exelon Indication

For the treatment of mild to moderate Alzheimer's disease.

Exelon Pharmacology

Rivastigmine is a parasympathomimetic and a reversible cholinesterase inhibitor. Rivastigmine is indicated for the treatment of mild to moderate dementia of the Alzheimer's type. Pathological changes in Dementia of the Alzheimer type involve cholinergic neuronal pathways that project from the basal forebrain to the cerebral cortex and hippocampus. These pathways are thought to be intricately involved in memory, attention, learning, and other cognitive processes. While the precise mechanism of rivastigmine's action is unknown, it is postulated to exert its therapeutic effect by enhancing cholinergic function. This is accomplished by increasing the concentration of acetylcholine through reversible inhibition of its hydrolysis by cholinesterase. If this proposed mechanism is correct, rivastigmine's effect may lessen as the disease process advances and fewer cholinergic neurons remain functionally intact.

Exelon Absorption

No information avaliable

Exelon side effects and Toxicity

No information avaliable

Exelon Patient Information

Caregivers should be advised of the high incidence of nausea and vomiting associated with the use of the drug along with the possibility of anorexia and weight loss. Caregivers should be encouraged to monitor for these adverse events and inform the physician if they occur. It is critical to inform caregivers that if therapy has been interrupted for more than several days, the next dose should not be administered until they have discussed this with the physician.

Exelon Organisms Affected

Humans and other mammals